641 views
Speakers: Ekaterina Anatolyevna Polyakova - MD, PhD, Associate Professor of the Department of Faculty Therapy with a Course in Endocrinology, Cardiology with the Clinic named after Academician G.F. Lang of the First Saint Petersburg State Medical University named after Academician I.P. Pavlov. Head of the Atherosclerosis Center of the First Saint Petersburg State Medical University named after Academician I.P. Pavlov, Leading Researcher of the Research Department of Myocardial Metabolism of the Research Institute of Experimental Medicine of the Almazov National Medical Research Center Viktor Yuryevich Kalashnikov - Corresponding Member of the Russian Academy of Sciences, MD, Professor, Deputy Director of the Endocrinology Service Coordination Center. Head of the Department of Cardiology and Vascular Surgery, National Research Center of Endocrinology, Ministry of Health of the Russian Federation Program: 17:00 - 17:30 - The drug Omega-3 polyunsaturated fatty acids is the first among equals in managing cardiovascular risk in hypertriglyceridemia. Speaker: E.A. Polyakova. 17:30 - 18:00 - Triglycerides - a marker or a target. Speaker: V.Yu. Kalashnikov. The webinar will be devoted to the analysis of the role of polyunsaturated fatty acids in the correction of hypertriglyceridemia. Using a clinical case as an example, the lecturers will tell in detail about the rules for correcting lipid profile disorders, including mixed dyslipidemia. 0:00 Start screen 0:50 Opening remarks 1:18 E.A. Polyakova Omega-3 polyunsaturated fatty acid drug is first among equals in managing cardiovascular risk in hypertriglyceridemia. 25:38 Kalashnikov V.Yu. Triglycerides - marker or target. 43:31 Answers to questions